News from Business Insider Markets
What is your interest today?
Bitcoin
Crypto
Btc
Tariffs
Ceo
Cryptocurrency
Crypto Assets
Investors
Stocks
Ethereum
Stock
Stock Market
Shares
Markets
Price
Xrp
Blockchain
Investment
Sec
Eth
Etf
Stablecoin
Trade
Earnings
Revenue
Solana
China
Coinbase
Index
Bse
Token
Nasdaq
Usd
Wall Street
Ipo
Trade War
Inflation
Economy
Interest Rates
Profit
Digital Assets
Nvidia
Sp 500
Gold
Binance
Sensex
Treasury
Federal Reserve
Trade Deal
Company
Digital Currencies
Buyers Guide
Web3auth
Oxide
Cic
Sports Network
Mortgage Bankers Association
Digital Asset Stockpile
Aircraft Purchases
Regulated Liability Network
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search Business Insider Markets headlines…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
Business Insider Markets • Jun 03, 2025
Kamari Pharma Announces Closing of $23 Million Financing to Advance its First-In-Class Oral TRPV3 In...
Kamari Pharma secured $23 million in funding led by BRM Group and Pontifax to support the clinical development of its novel oral TRPV3 inhibitor targeting rare genetic skin conditi...
Read Full Article →